ArticleMedical microbiology and immunology2025
YopP modulates bacterial virulence and systemic dissemination in Peyer´s patches during murine Yersinia enterocolitica infection.
Article in Medical microbiology and immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Yersinia enterocolitica (Ye) typically causes gastroenteritis and mesenteric lymphadenitis and can also spread extra-intestinally. Yersinia outer protein P (YopP) has been shown to induce cytotoxicity and suppress pro-inflammatory responses in in vitro studies. However, the role of YopP during in vivo Ye infection remains incompletely understood. Here, we show that, contrary to expectations for a virulence factor, a YopP-deficient strain (Ye ΔyopP) increases bacterial dissemination from Peyer's patches (PP) to mesenteric lymph nodes (MLN) and the spleen in intragastrically infected mice. Additionally, inhibition of cytotoxicity by suramin treatment in mice promoted wild-type Ye (Ye WT) dissemination to levels comparable to Ye ΔyopP. Moreover, the absence of YopP enhanced neutrophil and macrophage infiltration and increased pro-inflammatory cytokine production in PP, while decreasing IL-10 levels in PP, MLN and the spleen. Notably, the CD11b⁺ dendritic cell (DC) subpopulation in PP following Ye ∆yopP infection did not reach the levels observed in Ye WT. However, Ye-carrying DCs were significantly elevated after infection with GFP-expressing Ye ∆yopP (Ye ∆yopP GFP⁺). Blocking DC migration by FTY720 treatment in Ye ΔyopP-infected mice significantly reduced the MLN bacterial burden, indicating that YopP regulates Ye-transporting DCs from PP to MLN. Overall, our findings provide insights into how YopP participates in host-pathogen interactions, seemingly benefiting the host while simultaneously facilitating bacterial evasion from early immune clearance. These findings contribute to understanding the impact of YopP on the clinical outcome of Ye infection.
Indexed as
Identifiers
41247427What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.